Related Experiment Videos
Relative contribution of chloride channels and transporters to regulatory volume decrease in human glioma cells
Nola Jean Ernest1, Amy K Weaver, Lauren B Van Duyn
1Department of Neurobiology, University of Alabama at Birmingham, USA.
American Journal of Physiology. Cell Physiology
|January 22, 2005
Summary
Human glioma cells regulate volume via chloride channels and transporters, crucial for thriving in brain tumors. Chloride channels contribute 60-70% to this volume regulation.
Area of Science:
- Cellular Biology
- Neuroscience
- Oncology
Background:
- Primary brain tumors, such as gliomas, are often associated with peritumoral edema.
- Glioma cells' ability to thrive in osmotically altered environments suggests active volume regulation mechanisms.
Purpose of the Study:
- To investigate volume regulation in human glioma cells.
- To determine the relative contribution of chloride (Cl(-)) channels and transporters to this process.
Main Methods:
- Utilized cultured astrocytes and human glioma cells (D54-MG and patient biopsies) subjected to hyposmotic challenges.
- Employed specific inhibitors for Cl(-) channels (NPPB, Cd(2+)) and K(+)-Cl(-) cotransporters (DIOA).
- Investigated temperature dependence of volume regulation (15°C) to differentiate channel vs. transporter activity.
Main Results:
- Glioma cells exhibited regulatory volume decrease (RVD), with complete volume recovery, unlike astrocytes.
- RVD in glioma cells was significantly inhibited by Cl(-) channel blockers (NPPB + Cd(2+)) and moderately by KCC inhibitor (DIOA).
- At 15°C, Cl(-) channel blockers completely abolished RVD, while DIOA-sensitive regulation was lost, indicating channels dominate at lower temperatures.
Conclusions:
- Chloride channels play a dominant role (60-70%) in glioma cell volume regulation during RVD, with transporters contributing 30-40%.
- Identified potential protein candidates involved in RVD, including ClC-2, ClC-3, ClC-5, ClC-6, ClC-7, KCC1, and KCC3a.
- Understanding these mechanisms may offer new therapeutic targets for managing brain tumors and associated edema.